type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects were patients with type 2 diabetes mellitus (World Health Organization, 1999), aged 50-82 years, with a disease duration of 10-30 years, stable use of insulin glargine + 1 Insulin aspartate before primary dining model (1 + 1 mode) for at least 3 months; HbA1C> 7.5% but 11.0mmol/l for at least one meal. Willing and able to use blood glucose meter for blood glucose monitoring, willing and able to fill out the research questionnaire, willing and able to sign the written informed consent before enrollment.
Exclusion criteria
Exclusion criteria: (1) non-type 2 diabetes (such as type 1 diabetes, diabetes secondary to pancreatic disease, taking drugs or chemicals); (2) pregnant women, pregnant or lactating women; (3) accompanied by acute complications of diabetes such as diabetic ketoacidosis, hypertonic faint patients; (4) liver and kidney dysfunction patients (alanine aminotransferaseexceeds limit of more than 2 times; significant kidney disease or serum creatinine =133umol/L); (5) diabetic patients associated with other endocrine and metabolic diseases, newly discovered tumors, autoimmune diseases; (6) diabetic patients with thyroid, pituitary, adrenal and other diseases; (7) Participated in other researchers at the same time orwithin 3 months; (8) using steroid hormone therapy and so on within recent 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose;2hPG;HbA1C;BMI;Daily insulin dose;Hypoglycemic events;DTSQs/c; | — |
Countries
China
Contacts
The Affiliated Hospital of Ningbo University School of Medicine